"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
“Our findings open the door for the development of treatments to target specific symptoms of psychosis depending on an individual subject’s symptom profile," says Guillermo Horga, MD, PhD
“More than any other provider group, primary care providers offer greater potential for expanding access to buprenorphine treatment,” says Dr. Mark Olfson.
The practice of social distancing and aggressive testing "creates more anxiety and a fear of being shunned. We are seeing a rise in mental health issues," said Dr. Kathleen Pike.
Dr. Jeffrey Lieberman said teletherapy "is ideally suited to providing mental health care under the current circumstances. And it's being used more now than ever in history."
Dr. Jeffrey Cohen said, "Studies suggest that clinical levels of anxiety increased in China after the COVID-19 outbreak and we can expect clinical levels of anxiety to rise in the U.S."
The results "indicate that KarXT, if approved, could represent a game-changing therapeutic advance in the treatment of patients with schizophrenia,” noted Dr. Jeffrey Lieberman.